REFERENCES
1. Maron B.J., Ommen S.R., Semsarian C., Spirito P., Olivotto I., Maron M.S. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014; 64 (1): 83–99. DOI: https://doi.org/10.1016/j.jacc.2014.05.003
2. Leonty’eva I.V., Nikolaeva E.A. Mitochondrial cardiomyopathies. Rossiyskiy vestnik perinatologii i pediatrii [Russian Bulletin of Perinatology and Pediatrics]. 2016; 61 (3): 22–30. DOI: https://doi.org/10.21508/1027-4065-2016-61-3-22-30 (in Russian)
3. Li J., Dong J., Ouyang J., Cui J., Chen Y., Wang F., Wang J. Synthesis, characterization, solubilization, cytotoxicity and antioxidant activity of aminomethylated dihydroquercetin. Med Chem Commun. 2016; 8 (2): 353–63. DOI: https://doi.org/10.1039/c6md00496b
4. Islam J., Shree A., Vafa A., Afzal S.M., Sultana S. Taxifolin ameliorates benzo[a]pyrene-induced lung injury possibly via stimulating the Nrf2 signalling pathway. Int Immunopharmacol. 2021; 96: 107566. DOI: https://doi.org/10.1016/j.intimp.2021.107566
5. Li Z., Yu Y., Li Y., Ma F., Fang Y., Ni C., et al. Taxifolin attenuates the developmental testicular toxicity induced by di-n-butyl phthalate in fetal male rats. Food Chem Toxicol. 2020; 142: 111482. DOI: https://doi.org/10.1016/j.fct.2020.111482
6. Liu F., Ma Y., Xu Y. Taxifolin shows anticataractogenesis and attenuates diabetic retinopathy in STZ-diabetic rats via suppression of aldose reductase, oxidative stress, and MAPK signaling pathway. Endocr Metab Immune Disord Drug Targets. 2020; 20 (4): 599–608. DOI: https://doi.org/10.2174/1871530319666191018122821
7. Zinchenko V.P., Kim Yu.A., Tarakhovsky Yu.S., Bronnikov G.E. Biological activity of water-soluble nanostructures of dehydroquercetin with cyclodextrins. Biofizika [Biophysics]. 2011; 56 (3): 433–8. (in Russian)
8. Kondrashova M.N., Khunderyakova N.V., Zakharchenko M.V., Yachkula T.V., Plyasunova S.A., Sukhorukov V.S., et al. Method for determining the functional state of mitochondria in the human body by indicators of enzyme activity and microscopic appearance of blood lymphocytes on a smear (Cytobiochemical method). Meditsinskiy alfavit. Sovremennaya laboratoriya [Medical Alphabet. Modern Laboratory]. 2016; 3 (19): 83–5. (in Russian)
9. Khunderyakova N.V., Zakharova N.M. Evaluation of succinate dehydrogenase and lactate dehydrogenase activity in blood lymphocytes in Yakut ground squirrels Spermophilus undulatus during hibernation and in an active state. Byulleten’ eksperimental’noi biologii i meditsiny [Bulletin of Experimental Biology and Medicine]. 2020; 169 (4): 426–30. DOI: https://doi.org/10.1007/s10517-020-04906 (in Russian)
10. Frelikh G.A., Yanovskaya E.A., Polomeeva N.Yu., Timofeev M.S., Slepichev V.A., Bryushinina O.S., et al. Determination of mitochondrial functional state in vital tissues by cytobiochemical analysis of peripheral blood lymphocytes. Open J Endocr Metab Dis. 2013; 3 (2): 10–3. DOI: https://doi.org/10.4236/ojemd.2013.32A002
11. Khunderyakova N.V., Yachkula T.V., Zakharchenko M.V., Plyasunova S.A., Sukhorukov V.S., Baranich N.I., et al. Cytobiochemical biomarkers of the state of mitochondria in humans. J World Mitochondria Soc. 2017; 2 (2): 118. DOI: https://doi.org/10.18143/JWMS_v2i2_1930
12. Skupnevsky S.V., Pukhaeva E.G., Badtiev A.K., Rurua F.K., Batagova F.E., Farnieva Zh.G. Functional features of peripheral blood lymphocytes in the dynamics of autoimmune arthritis in rats. Mezhdunarodniy zhurnal prikladnykh i fundamental’nykh issledovaniy [International Journal of Applied and Fundamental Research]. 2019; (12): 82–7. (in Russian)
13. Siddiqui M.A., Ahmad U., Khan A.A., Ahmad A., Badruddeen A., Khalid M., et al. Isoprenaline: a tool for inducing myocardial infarction in experimental animals. Int J Pharm. 2016; 6 (2): 138–44.
14. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95 (2): 351–8. DOI: https://doi.org/10.1016/0003-2697(79)90738-3
15. Venediktova N.I., Gorbacheva O.S., Belosludtseva N.V., Fedotova I.B., Surina N.M., Poletaeva I.I., et al. Energetic, oxidative and ionic exchange in rat brain and liver mitochondria at experimental audiogenic epilepsy (Krushinsky–Molodkina model). J Bioenerg Biomembr. 2017; 49: 149–58. DOI: https://doi.org/10.1007/s10863-016-9693-5
16. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012; 21: 297–308. DOI: https://doi.org/10.1016/j.ccr.2012.02.014
17. Pavlova N.N., Thompson C.B. The emerging hallmarks of cancer metabolism. Cell Metab. 2016; 23: 27–47. DOI: https://doi.org/10.1016/j.cmet.2015.12.00
18. Kolwicz S.C. Jr, Tian R. Glucose metabolism and cardiac hypertrophy. Cardiovasc Res. 2011; 90 (2): 194–201. DOI: https://doi.org/10.1093/cvr/cvr071
19. Drent M., Cobben N.A., Henderson R.F., Wouters E.F., van Dieijen-Visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J. 1996; 9 (8): 1736–42. DOI: https://doi.org/10.1183/09031936.96.09081736
20. Luengo A., Li Z., Gui Dan Y., Spranger S., Matheson N.J., Vander Heiden M.G. Increased demand for NAD+ relative to ATP drives aerobic glycolysis. Mol Cell. 2021; 81: 691–707. DOI: https://doi.org/10.1016/j.molcel.2020.12.012
21. Ametov A.S., Konieva M.Yu., Luk’yanova I.V. Cardiovascular system in thyrotoxicosis. Consilium Medicum [Consilium Medicum]. 2003; 5 (11): 660–3. (in Russian)